Jacqueline Aparecida Torres

CV Lattes ORCID

Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. Escola Paulista de Medicina (EPM) (Institutional affiliation from the last research proposal)
Birthplace: Brazil

Jacqueline Aparecida Torres in research grants and scholarships supported by FAPESP.

News published in Agência FAPESP Newsletter about the researcher

More items Less items

TITULO

Articles published in other media outlets ( ):

More items Less items

VEICULO: TITULO (DATA)

Scholarships in Brazil

Ongoing (most recent)

Abstract
Immunotherapy has provided beneficial results for cancer patients. Recently, the ANVISA, based on the KEYNOTE-355 study, approved the use of the immune checkpoint inhibitor (ICI) pembrolizumab plus chemotherapy for patients with unresectable locally recurrent or metastatic triple-negative breast cancer, with PD-L1 expression e 10. Although the results are encouraging, evidence suggests th…
Evaluation of soluble PD-L1 in combination with its protein expression in circulating tumor cells and other soluble factors as serum markers of treatment response in patients with Non-Metastatic Triple Negative Breast Cancer, BP.DR

Virtual Library in numbers * Updated data on August 16, 2025

Total / Available in English

1 / 1	Ongoing scholarships in Brazil

Associated processes

Most frequent collaborators in research granted by FAPESP

Ludmilla Thomé Domingos Chinen

Keywords used by the researcher

Biological Sciences Immunology

Please report errors on the page using this form.

Short URL

Abstract